All four "symmetrical" regioisomers of ED-110, an indolocarbazole derivativ
e having potent activity against human topoisomerase I (Topo I) were synthe
sized. The isomer containing hydroxyl groups in the 3- and 9-positions was
approximately ten-fold more active against Topo I, and 5- to 35-fold more a
ctive against human solid tumor cell lines in vitro, relative to ED-110. (C
) 1999 Elsevier Science Ltd. All rights reserved.